Abstract
Mifepristone and misoprostol sequential regimen side effects, complications and safety
Sitruk-Ware,Regine
Contraception 74(1): 48-55
Publication date: 2006
Exhibiting a strong affinity to the progesterone and the glucocorticoid receptors, mifepristone exert competitive antagonism to these hormones both in in vitro and in animal experiments. Due to its antiprogesterone activity, it was proposed that mifepristone be used for the termination of early human pregnancy. Mifepristone, at a dose of 600 mg initially used alone, was then used with a subsequent low dose of prostaglandin that led to a success rate of 95% as a medical method for early termination of pregnancy (TOP), and the occurrence of continuing pregnancy was reduced to
Get Involved
- Make a contribution to the Population Council
- Sign up to receive e-mail announcements
Connect
